ethyl 2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoate, 98%, 2.5g

4-(4-Chlorophenyl)cyclohexanecarboxylic acid, 95.0%, 100g

Octavinyl-T8-silsequioxane, 25g

Methyl 2-((diphenylmethylene)amino)-5,6,7,8-tetrahydronaphthalene-1-carboxylate, 97%, 500mg

(R)-3-(3-(3,4-DIMETHOXYPHENYL)-1-HYDROXYPROPYL)PHENOL, 95%, 1g

(R)-2-((R)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-(1H-indol-3-yl)propanoic acid, 97.0%, 1g

4-(2-Bromoethyl)benzoic Acid>98.0%(T)25g

Phenosafranine, 98%, 25g

SDS pellets, 5 kg

N-(2-Chlorophenyl)-3-oxobutanamide, 95.0%, 500g

Ethyl imidazo[1,5-a]pyridine-5-carboxylate, 95.0%, 1g

1-Benzyl 2-ethyl piperazine-1,2-dicarboxylate hydrochloride, 98%, 1g

4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 25g